Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: Herbalife is a global network marketing company selling weight management, nutritional supplements ("Inner Nutrition"), and personal care products ("Outer Nutrition") through over one million independent distributors in 59 countries. The company operates as a single reporting segment.
Key Financial Metrics
| Metric | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Sales | $372.1 million | $324.1 million |
| Gross Profit | $296.3 million | $260.4 million |
| Gross Margin | 79.6% | 80.4% |
| Operating Income | $51.1 million | $36.7 million |
| Net Income | $13.3 million | $(0.5) million (Loss) |
| Diluted EPS | $0.19 | $(0.01) |
| Operating Cash Flow | $25.0 million | $14.4 million |
| Cash and Equivalents (End of Period) | $103.7 million | $123.0 million |
| Total Debt (Current + Long-term) | $376.0 million | $486.2 million |
| Working Capital | $16.5 million | $(1.6) million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 14.8% year-over-year, driven by growth in the Americas (26.4%), Asia/Pacific Rim (30.0%), and Europe (5.8%), offset by a decline in Japan (10.1%).
- Profitability Turnaround: The company reported a net income of $13.3 million compared to a net loss of $0.5 million in the prior year. This improvement was driven by higher sales, favorable foreign currency impacts ($1.8 million), and lower interest expenses.
- Debt Reduction: Total debt decreased significantly from $486.2 million to $376.0 million. This was primarily due to the redemption of $110.0 million principal value of 9 1/2% Notes in February 2005.
- Expense Management: Selling, General & Administrative (SG&A) expenses as a percentage of net sales decreased from 33.3% to 29.6%, despite a nominal increase in total dollars due to higher sales volume.
- Inventory Provision: Gross margin percentage decreased slightly due to a $1.1 million provision for obsolete and slow-moving inventory, primarily in the U.S.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- 2005 Expectations: Management expects SG&A expenses to increase 5-6% over 2004 levels in absolute terms but decrease as a percentage of net sales. Capital expenditures are expected to reach up to $40.0 million in 2005, focused on IT systems and China expansion.
- Regional Strategy: Growth is expected to continue in the Americas (Mexico and Brazil) and Asia/Pacific Rim. In Japan, the company is implementing new product introductions and leadership changes to reverse a five-year sales decline.
- Distributor Metrics: The number of qualified supervisors increased 5.9% worldwide to 213,833. Volume Points increased 10.7% globally.
Risks and Contingencies
- Legal Proceedings: The company is a defendant in two class-action lawsuits: one alleging violations of the Telephone Consumer Protection Act (TCPA) regarding telemarketing, and another challenging marketing practices as "endless chain schemes." Management believes it has meritorious defenses.
- Product Liability/Regulatory: In February 2005, Herbalife voluntarily withdrew a specific product (Sesame & Herb tablet) from the Israeli market pending a Ministry of Health review regarding anecdotal reports of liver dysfunction. No causal link has been established, but the review is ongoing.
- Tax Audits: Subsidiaries are subject to tax audits in various countries with proposed additional taxes and penalties. Management contests these and believes adverse outcomes will not be material.
- Foreign Exchange: The company faces risk from currency fluctuations, as sales are in local currencies while many purchases are in U.S. dollars. Hedging strategies are in place to mitigate this.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new $225 million senior credit facility covenants, specifically leverage and fixed charge coverage ratios.
- Japan Turnaround: Monitor the effectiveness of new product launches and leadership changes in Japan to confirm if the sales decline trend is reversing.
- Legal Exposure: Track the status of the Mey and Minton class-action lawsuits for potential settlement costs or injunctions.
- Regulatory Status: Confirm the final outcome of the Israeli Ministry of Health review regarding the Sesame & Herb product and any potential impact on other markets.
- Inventory Levels: Review future quarters for additional provisions related to obsolete inventory, given the $1.1 million charge in Q1 2005.